The ICAP1 (integrin cytoplasmic domain-associated protein-1) is a specific intracellular binding protein of ␤1-integrins and the cerebral cavernous malformation (CCM) protein CCM1. ICAP1 recruits CCM1 to the cell membrane and activates CCM1 by changing its conformation. Because CCM1 plays a critical role for cardiovascular development, we hypothesized that its activator ICAP1 is involved in vascular differentiation.
I CAP1 (integrin cytoplasmic domain-associated protein-1; also known as ITGB1BP1 or Bodenin) is a small phosphoprotein with widespread expression during embryonic development. The ICAP1 protein was originally identified as an interaction partner of the ␤1-integrin cytoplasmic domain. [1] [2] [3] In humans, at least 2 splicing isoforms exist, the 200-aa-long ICAP1 (also known as ICAP1␣) and a 50-aa-shorter isoform (ICAP1␤), which is unable to bind ␤1-integrins. 1 The generation of global Icap1-deficient mice demonstrated that Icap1 plays an important role for bone development. Additionally, Ϸ20% of Icap1 Ϫ/Ϫ pups die shortly after birth from unknown causes, 4 suggesting that Icap1 has essential functions also in other organs.
Detailed cellular functions of ICAP1 are poorly understood. There is evidence that ICAP1 competes with TALIN1 for binding to ␤1-integrins to inhibit focal adhesion assem-bly, 5 cell adhesion, and migration. 6 However, ICAP1 was also described as an activator of cell migration in CHO cells, 3 which might be mediated by interaction with the small G protein RAP1 and the Rho kinase ROCK1. 7, 8 ICAP1 strongly interacts with the cerebral cavernous malformation (CCM) protein CCM1 (also known as KRIT1). 9 Ccm1 Ϫ/Ϫ mouse embryos die from severe cardiovascular defects. 10 In humans, loss-of-function mutations in the CCM1 gene frequently cause cerebral cavernous malformations (CCM). Such CCM lesions, which affect Ϸ0.5% of the human population, consist of grossly enlarged and disorganized microvessels in the brain parenchyma which can lead to headaches, seizures, and hemorrhagic stroke. 11 CCM1 builds a large protein complex, including CCM2 and CCM3, at the cell membrane, which also contains the lipids phosphatidylinositol (4,5)-bisphosphate (PIP 2 ) and phosphatidylinositol (1, 4, 5) -trisphosphate (PIP 3 ). 12 The formation of this complex seems to be a critical process, because a disruption by loss of CCM1, CCM2, or CCM3 leads to the same disease, although the CCM proteins are not related with each other. 11 Recently, it was shown that the ICAP1 protein can recruit CCM1 to the cell membrane. 8 CCM1 contains a FERM (band four-point-one/ezrin/radixin/moesin) domain and adopts 2 different conformations: a closed form where the N-terminal part of CCM1 interacts with its C-terminal part and an open conformation. ICAP1 is the only known protein that causes opening of the CCM1 protein, allowing further interaction with GTP-bound RAP1 and the lipid phosphatidylinositol (4,5)-bisphosphate (PIP 2 ). 8 Moreover, the expression of CCM1 stabilizes the ICAP1 protein. 13 Based on these reports in the literature, we hypothesized that ICAP1 should play a role for blood vessel development or maintenance.
Here, we show that ICAP1 functions as a negative regulator of endothelial cell sprouting by induction of DELTA-NOTCH signaling. NOTCH signaling is of utmost importance for controlling angiogenesis and balancing vascular endothelial growth factor (VEGF) functions. 14 Consequently, we found that blocking NOTCH activity prevented ICAP1mediated endothelial quiescence.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Endothelial Migration, Proliferation, Adhesion, Tube Formation, and Sprouting
Analyses of primary human umbilical vein endothelial cell (HUVEC) migration, proliferation, and spheroid sprouting in collagen beds of small interfering (si)RNA transfected or viral transduced HUVECs were performed as described. 15 Apoptosis was assayed with the Caspase-Glo 3/7 Assay (Promega).
Microarray Analyses
HUVECs at passage 2 were transduced with adenovirus expressing green fluorescent protein (GFP), ICAP1, or NOTCH1-intracellular domain in triplicate, and 36 hours later, total RNA was isolated using the RNeasy Kit (Qiagen). RNA quality was analyzed on an Agilent 2100 Bioanalyzer (Agilent Technologies). Biotin-labeled cRNA samples were prepared as described. 16 Hybridization on Illumina Human WG-6 v3.0 BeadChip was performed at 58°C in GEX-HCB buffer (Illumina). Spike-in controls for low, medium, and highly abundant RNAs were added, as well as mismatch control and biotinylation control oligonucleotides. After washing and blocking, array signals were developed by incubation with Cy3-streptavidin (Amersham Biosciences). Normalization and data analysis were performed with Illumina BeadStudio 3.1.3 and the GenomeStudio plug-in. Raw data were quantile normalized and the detection probability value was calculated by BeadStudio with an implemented method by comparing all beads of 1 probe with all negative beads on the chip. Differential expression of the groups was calculated with the "Illumina custom" error model. For multitesting corrections, the Benjamini-Hochberg algorithm was applied. Only probes with a detection probability value of Յ0.05 and a differential analysis probability value of Յ0.001 were used for data processing. Further data analysis was performed with CSC Chipster (http://chipster.csc.fi) and Ingenuity Pathway Analysis software (Ingenuity Systems).
Online Data Submission
Microarray data have been deposited in the NCBI Gene Expression Omnibus under accession code no. GSE18035.
Quantitative RT-PCR
Total RNA was isolated using the RNeasy Kit (Qiagen), and 2 g of RNA was transcribed into cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Quantitative RT-PCR (qPCR) was performed with the POWER SYBR Green Master Mix on an ABI StepOnePlus cycler. All PCR primer sequences are listed in the Online Table I .
Statistical Analysis
Results are expressed as meansϮSD. Comparisons between groups were analyzed by t test (2-sided) . Probability values of Ͻ0.05 were considered significant.
Results

ICAP1 Inhibits Endothelial Tube Formation and Sprouting
Based on the critical roles of ICAP1 to recruit CCM1 to the membrane and to open its conformation, 8 we hypothesized that ICAP1 may be a regulator of vascular differentiation. HUVECs express moderate levels of ICAP1 mRNA, as determined by RT-PCR and microarray data mining (Online Figure I ). HUVECs do not only express the full-length mRNA but also a 150-bp shorter mRNA isoform (Online Figure I ), resembling ICAP1␤. Forced adeno-or lentiviral expression of ICAP1 (the full-length isoform) in HUVECs disrupted their ability to form capillary networks on a Matrigel matrix. Compared to GFP expression as control, ICAP1 decreased total tube length and the number of branch points ( Figure 1A through 1C ).
HUVEC spheroids embedded in a collagen matrix mimic various steps of angiogenesis in vitro. 17 Adenoviral ICAP1 expression decreased VEGF-or fibroblast growth factor (FGF)2-stimulated angiogenic sprouting, as measured by total sprout length ( Figure 1D and 1E ). Although the number of initial sprouts was increased, these protrusions stopped growing immediately and remained significantly shorter than controls ( Figure 1F and 1G). When HUVECs overexpressing ICAP1 (labeled with green fluorescent dye) were mixed with control cells overexpressing mCherry (red fluorescence), most of the well-defined and elongated sprouts were formed exclusively by control cells, suggesting a cell autonomous effect ( Figure 1H and Online Movie I). ICAP1 loss-of-function in HUVECs was achieved with 3 independent siRNA duplexes (each Ϸ50% mRNA reduction) or 3 lentiviral small interfering hairpin (sh)RNAs (each Ϸ80% mRNA reduction) ( Figure 2A ). Both strategies caused a strong enhancement of sprouting angiogenesis in collagen beds ( Figure 2B ). Silencing ICAP1 increased the average number and the average length of sprouts even under basal conditions ( Figure 2B through 2E). This was also observed when HUVECs expressing shRNA against ICAP1 were mixed with control cells in individual spheroids ( Figure 2F and Online Movie II). Taken together, the combination of gain-and loss-of-function experiments identified ICAP1 as a novel negative regulator of angiogenesis.
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ICAP1 Regulates Blood Vessel Formation In Vivo
A functional human vasculature can be engineered by grafting human endothelial cells in a Matrigel/fibrin matrix containing VEGF and FGF2 into the flanks of immunocom- Figure 1 . ICAP1 inhibits angiogenesis. A, HUVECs were transduced with an ICAP1-expressing adenovirus, and 48 hours later, ICAP1 protein expression was determined by Western blotting. B and C, GFP-expressing HUVECs plated on Matrigel matrix formed a regular capillary network, whereas ICAP1 expression inhibited such network formation. D, HUVEC spheroids were embedded in a collagen matrix without (basal) or with addition of growth factors (25 ng/mL VEGF or FGF2). Twenty-four hours later, the formation of capillary sprouts was documented and analyzed. E, Cumulative sprout length was decreased by ICAP1, whereas the number of sprouts was increased already under basal conditions (F). G, The average length of sprouts was strongly reduced after ICAP1 expression. H, HUVECs overexpressing ICAP1 (labeled with the green dye PKH67) were equally mixed with control HUVECs expressing mCherry (additionally labeled with the red dye PKH26) before spheroid formation and sprouting in collagen gels. Confocal laser microscopy revealed that regular sprouts are predominantly formed by control HUVECs, whereas ICAP1 strongly inhibited this process. Scale bars, 100 m. *PϽ0.05.
promized mice. The developing vessels form a complex network that connects to the mouse vasculature and is perfused. 18, 19 This assay enabled us to study the role ICAP1 for blood vessel development also in vivo. HUVECs were lentivirally infected with ICAP1 cDNA, shRNA against ICAP1 or control and studied for their ability to form blood vessels 4 weeks after xenotransplantation ( Figure 3A ). Compared to expression of a control shRNA together with GFP, the forced expression of ICAP1 decreased blood vessel formation. Oppositely, silencing of ICAP1 led to the formation of a denser blood vessel network ( Figure 3B and 3C) comparable to the effect observed in vitro. These findings correlate to the cellular experiments and demonstrate that acute dysregulation of ICAP1 can interfere with blood vessel formation. Furthermore, ICAP1-silenced endothelial cells often formed vessels with larger lumina. This is reminiscent to CCM1-silenced endothelial cells which align to strongly enlarged vessels in this assay. 20 Interestingly, we found that forced ICAP1 expression led to an accumulation of CCM1 protein (Online Figure II) . Given that CCM1 can stabilize the ICAP1 protein, 13 this suggests that the ICAP1/CCM1 interaction is necessary to stabilize both proteins.
ICAP1 Controls Endothelial Proliferation, Apoptosis, and Migration
To determine what cellular processes are underlying the block of sprouting angiogenesis, we measured endothelial proliferation, apoptosis and migration after ICAP1 gain-offunction in HUVECs. Forced ICAP1 expression decreased bromodeoxyuridine (BrdUrd) incorporation ( Figure 4A ). This was accompanied by strongly induced mRNA levels of the cell cycle inhibitors p21 (WAF1/CIP1) and p27 (KIP1) ( Figure 4B ). Oppositely, silencing of ICAP1 expression increased cell proliferation and lowered the expression of p27 ( Figure 4A and 4B). ICAP1 expression did also decrease the amount of phosphorylated extracellular signal-regulated kinase (ERK)1/2 proteins, whereas knockdown of ICAP1 increased ERK1/2 phosphorylation ( Figure 4C ). The decreased proliferation rate of HUVECs after ICAP1 expression was not a result of increased apoptosis because we could not detect more apoptotic cells (Caspase-3 and -7 activities) after adenoviral ICAP1 expression ( Figure 4D ). ICAP1 even prevented from staurosporine-induced apoptosis ( Figure 4D ). AKT (also known as protein kinase B [PKB]) is the prototypic mediator of cell survival 21, 22 ; and ICAP1 expression significantly increased the amounts of active AKT protein phosphorylated at serine 473, whereas ICAP1-silenced HUVECs had lower phospho-AKT levels ( Figure 4C ).
Chemotactic migration under basal condition of ICAP1expressing HUVECs was enhanced, but not toward a VEGF or FGF2 source ( Figure 5A ), supporting the notion that the initial number of cellular protrusions from spheroids was increased by ICAP1 expression. Silencing of ICAP1, however, reduced migration of HUVECs in the Boyden chamber ( Figure 5B ). It was shown recently, that CCM proteins can inhibit the activity of Rho kinase (ROCK) and that ROCK activity is excessively high in CCM lesions. [23] [24] [25] The ICAP1 protein is known to interact with CCM1 and ROCK1. 7 Therefore, we analyzed the impact of ICAP1 expression on ROCK activity in HUVECs. Similar to silencing of CCM1 or CCM2, knockdown of ICAP1 also led to a profound increase in ROCK activity as measured by phosphorylation of the regulatory myosin-binding subunit MYPT1. Correspondingly, overexpression of ICAP1 decreased the amount of phosphorylated MYPT1 at threonine 696 ( Figure 5C and 5D ). sufficiently repressed mRNA levels in HUVECs. B, Knockdown of ICAP1 strongly increased sprouting angiogenesis in collagen beds. C through E, Quantification. ICAP1 depletion led to a higher number of sprouts per spheroid and to a longer average sprout length causing strongly elevated cumulative sprout lengths. F, HUVECs expressing lentiviral shRNA against ICAP1 were labeled with the green dye PKH67 and equally mixed with control HUVECs transduced with lentivirus expressing mCherry (and additional staining with red dye PKH26). Confocal microscopy revealed that ICAP1 knockdown led to formation of more and longer sprouts. Scale bars, 100 m. *PϽ0.05.
ICAP1 Activates DELTA-NOTCH Signaling
We have obtained data that CCM1 can activate DELTA-NOTCH signaling, 20 a potent cascade inhibiting endothelial sprouting and proliferation. 14 Given the finding that ICAP1 activates CCM1, 8 we determined if ICAP1 acts genetically upstream of NOTCH. Adenoviral ICAP1 expression in HUVECs caused a substantial increase in cleaved and thus active NOTCH1 protein as determined by Western blotting (Figure 6A, inset) . Consequently, mRNA levels of the classical downstream NOTCH target genes HEY1, HEY2 and HES5 were Ͼ10-fold increased ( Figure 6A ). NOTCH receptors are activated by binding to ligands of the DELTA or JAGGED families. Whereas JAG1 mRNA was not changed, ICAP1 induced transcription of the DELTA ligands DLL4 and DLL1 ( Figure 6A and data not shown). Consistently, lower mRNA amounts of DLL1 and DLL4 were detected after ICAP1 knockdown ( Figure 6B ). The same observations were made by analyzing the amounts of DLL4 protein by Western blotting (Figure 6C ).
It was shown recently that AKT is able to induce NOTCH activity in different cell types, 26, 27 and that NOTCH can further promote AKT phosphorylation by inhibition of the phosphatase PTEN. 28 Consistently, the ICAP1-induced phosphorylation of AKT ( Figure 4C ) could not be blocked by the NOTCH inhibitor DAPT (N-[(3,5-difluorophenyl)acetyl]-Lalanyl-2-phenyl]glycine-1,1-dimethylethyl ester) in HUVECs ( Figure 6D ). However, the ICAP1-mediated decrease of ERK phosphorylation was dependent on NOTCH signaling because DAPT treatment prevented this effect of ICAP1 ( Figure 6E ).
Interference With DLL4-NOTCH Signaling Leads to Similar Endothelial Defects As ICAP1 Dysregulation
To directly compare the effects of DLL4-NOTCH with those of ICAP1 in HUVECs, we analyzed siRNA-mediated DLL4 silencing and adenoviral NOTCH1-ICD (intracellular domain, cleaved, "active" NOTCH1) expression. Overexpression of NOTCH1-ICD in HUVEC spheroids fully recapitu- lated the effects seen with ICAP1 expression (Online Figure  III) . The number of initial endothelial protrusions was significantly increased, these protrusions did not form capillary tubules and remained shorter than control (Online Figure III , a through d). According to forced ICAP1 expression, also NOTCH1-ICD inhibited cellular proliferation (Online Figure  IV, a) . However, NOTCH1-ICD also inhibited chemotactic migration toward VEGF (Online Figure IV, b ).
Silencing DLL4 with 3 independent siRNA duplexes completely phenocopied the effects of ICAP1 knockdown in HUVECs (Online Figure V , and data not shown). We observed increased capillary sprouting (Online Figure V, b and c) and proliferation (Online Figure V, d) , although migration through collagen-coated filters was also reduced (Online Figure V, e ).
Inhibition of NOTCH Activity Rescues the ICAP1 Effects
NOTCH signaling can very efficiently be blocked by preventing cleavage of NOTCH receptors with the ␥-secretase inhibitor DAPT. Treatment with 25 mol/L DAPT was sufficient to restore responsiveness to VEGF and FGF2 and to allow almost normal sprouting of HUVECs after ICAP1 overexpression. (Figure 6F ). DAPT treatment could also prevent the excessive induction of the NOTCH target genes HEY1, HEY2 and HES5 in ICAP1-expressing HUVECs ( Figure 6G ). Furthermore, DAPT treatment could also rescue tube formation on Matrigel after ICAP1 expression (Online Figure VI) . Thus, NOTCH acts downstream of ICAP1 to repress angiogenic sprouting.
Global Gene Expression Patterns of ICAP1 and NOTCH1-ICD-Expressing HUVECs
The global gene expression patterns of ICAP1 and active NOTCH1 (NOTCH1-ICD) expressing HUVECs were deter- RNA interference against ICAP1 slightly increased endothelial proliferation. B, qPCR 48 hours after lentiviral transduction with an ICAP1 vector showed massive upregulation of the cell cycle inhibitors p21 and p27, whereas ICAP1 knockdown decreased p21 and p27 expression. C, ICAP1 inhibited phosphorylation of ERK1/2. The prosurvival signaling molecule AKT1 was strongly activated 48 hours after adenoviral ICAP1 transduction, as shown by increased phosphorylation at serine 473. D, The apoptosis rate was not altered in ICAP1-expressing HUVECs under normal growth conditions. Incubation with staurosporine (250 nmol/L) for 2 hours induced apoptosis in control cells significantly stronger than in ICAP1expressing cells. *PϽ0.05. mined by microarray analysis and compared to GFP expression as control. A total of 290 transcripts were significantly regulated by NOTCH1-ICD (Online Table II ) and 119 transcripts by ICAP1 (Online Table III ). Ninety-one of the 119 ICAP1-regulated genes (76%) were coregulated by both proteins (Online Table IV and Online Figure VII, a and b) . Functional clustering revealed that these are primarily involved in cell proliferation and migration (Online Figure VII,  c) , and that these are intimately connected with each other (Online Figure VIII) . Thus, ICAP1 acts a potent inducer of a NOTCH-regulated genetic network.
ESM1 Silencing Inhibits Angiogenesis
One of the strongest coregulated genes in the microarray studies was the endothelial cell-specific molecule-1 (ESM1, also known as Endocan) -an early target of VEGF signaling. 29, 30 ESM1 was 3.7-and 6.5-fold downregulated by ICAP1 and NOTCH1, respectively. To test if this contributes to the ICAP1-induced block of sprouting angiogenesis, we silenced the endogenous expression of ESM1 in HUVECs using 2 independent siRNA ( Figure 7A ). ESM1-silenced HUVECs were indeed strongly impaired to form capillary sprouts and reacted only poorly to VEGF stimulation ( Figure 7B and 7C) . Forced lentiviral expression of ESM1 enhanced endothelial sprouting in collagen beds ( Figure 7D through 7F) . Thus, we conclude that ESM1 is a critical proangiogenic molecule whose expression is repressed by ICAP1 and NOTCH1 to prevent sprouting angiogenesis. In summary, this study describes ICAP1 as a novel antiangiogenic factor and as a novel upstream regulator of the DELTA-NOTCH cascade. Figure 6 . ICAP1 acts upstream of DELTA-NOTCH signaling. A, qPCR 48 hours after adenoviral transduction. mRNA levels of NOTCH ligands DLL1, DLL4, and target genes HEY1, HEY2, and HES5 were excessively increased in ICAP1-expressing HUVECs compared to GFP control. Inset, Higher amounts of cleaved NOTCH proteins indicate strong activation of NOTCH signaling. B, Reduction of ICAP1 by siRNA was followed by a decrease of NOTCH ligands DLL1 and DLL4 mRNA expression. C, ICAP1 expression led to higher DLL4 protein amounts. D, The NOTCH cleavage inhibitor DAPT did not prevent ICAP1-induced AKT phosphorylation. E, DAPT prevented the inhibition of ERK phosphorylation after expression of ICAP1. F, ICAP1 expression reduced capillary sprouting of HUVECs under basal conditions and after VEGF stimulation. DAPT-mediated (25 mol/L) inhibition of NOTCH signaling increased sprouting under basal conditions. The combination of ICAP1 expression with DAPT treatment could almost completely normalize the sprouting behavior of HUVECs. G, HUVECs were transduced with adenovirus expressing ICAP1 or GFP as control. Twelve hours later, 25 mol/L DAPT or DMSO as control was added for 12 hours and mRNA was prepared. qPCR shows that treatment with DAPT abolished ICAP1mediated induction of NOTCH ligands and NOTCH target genes. Scale bars, 100 m. *PϽ0.05.
Discussion
The formation of the vascular system requires complex regulation and coordination of cell proliferation, migration, matrix adhesion, and cell-cell signaling. Initially, potent endothelial growth factors like VEGF activate endothelial cells and stimulate their migration capacity and proliferation. Immediately thereafter other factors must be activated to select only individual endothelial cells which guide a novel sprout, whereas neighboring cells are returned to quiescence. During the last years it became evident that the DELTA-NOTCH cascade is essential for this process of selecting individual tip cells guiding the new sprout and preventing further branching and sprouting in neighboring cells. 14 VEGF, hypoxia, and FOXC1/2 are potent inducers of endothelial DLL4-NOTCH signaling [31] [32] [33] ; however, involvement of additional factors modulating such a critical cascade can be expected.
Our data showed that the CCM1-activating protein ICAP1 is a novel regulator of angiogenesis and of DELTA-NOTCH signaling. We detected strongly enhanced sprouting after loss of ICAP1 in HUVECs, demonstrating an inhibitory function for neovascularization. This was underscored by an impaired sprouting and tube-formation capacity after forced ICAP1 expression. Interestingly, in this setting HUVECs could no longer respond to VEGF or FGF2 stimulation but the cells formed significantly more cellular protrusions out of the spheroids. This might be attributable to the increased migration rates under basal conditions after ICAP1 gain-of-function. However, these initial sprouts remained very short and did not form an obvious lumen. The formation of novel capillaries requires the formation of novel endothelial cells. Yet, proliferation was potently impaired by ICAP1 as shown by reduced BrdUrd incorporation and ERK phosphorylation, as well as induction of cell cycle inhibitors p21 and p27. These findings suggest that ICAP1 executes cell type-specific effects because others have reported increased proliferation of MDCK and CHO cells after ICAP1 expression. 34 Nevertheless, our results are fully in line with the roles of NOTCH1 in endothelial cells which was described as a potent inhibitor of proliferation by p21 induction. 35 ICAP1 did not only inhibit proliferation, but it also prevented endothelial cells from damage-induced apoptosis. This was correlated with increased levels of phosphorylated AKT protein. Therefore, it appears that ICAP1 expression is needed to promote the quiescent state of the endothelium. Our experiments clearly demonstrated that ICAP1 is acting genetically upstream of NOTCH. This is based on several findings. Firstly, ICAP1, DLL4, and NOTCH1 showed highly similar effects during endothelial sprouting, proliferation and survival. Secondly, the impaired sprouting capacity after ICAP1 overexpression could be alleviated by NOTCH blockade and finally, the majority (Ϸ76%) of mRNA transcripts regulated by ICAP1 was very similar regulated by NOTCH1. It remains not fully answered how ICAP1 induces NOTCH. Two recent reports show that AKT is a strong inducer of NOTCH signaling and ligand gene expression. 26, 27 Because we detected strongly increased phospho-AKT levels, this might explain the potent induction of NOTCH signaling after ICAP1 expression.
The microarray screening analyses revealed ESM1 (also known as Endocan) as an interesting novel downstream target repressed by ICAP1 and NOTCH1. ESM1 had been described as an early target of VEGF and as a promoter of tumor growth and lymphangiogenesis. 29, 30, 36 ESM1 is predominantly expressed in tip cells compared to stalk cells 37 and has thus an opposite expression pattern compared with NOTCH1 activity. 14 Our data demonstrated that ESM1 is a strong stimulus to induce sprouting of endothelial cells. Thus, the loss of ESM1 might contribute to the block of sprouting angiogenesis after ICAP1 or NOTCH1 gain-of-function.
Our findings that ICAP1 stabilizes CCM1 and reduces the activity of Rho kinase strengthens the hypothesis that ICAP1 supports the functions of the CCM protein complex. It has been shown recently that CCM1 (KRIT1) stabilizes ICAP1 13 and that the loss of CCM1 or CCM2 causes excessive Rho kinase activity. [23] [24] [25] Icap1-deficient mice 4 do not show a classic angiogenesis defect as one would expect based on our data. However, the possibility for essential ICAP1 functions in the vasculature remains, eg, under stress conditions. It was reported that Ϸ20% of newborn Icap1 Ϫ/Ϫ mice die from unknown causes, 4 which could be cardiovascular defects. In the C57Bl6 strain the lethality is even higher. 38 We could show that ICAP1silenced human endothelial cells form a denser vascular network when xenotransplanted into immunocompromized mice. This assay allows the formation of a functional vasculature, with intact blood flow and the recruitment of mural cells, within 3 weeks after transplantation. 18 We have now successfully mimicked an acute endothelial-specific gene knockdown in vivo to elucidate ICAP1 functions that might not be seen in global knockout mice where compensatory mechanism might overcome the need for ICAP1. In conclusion, ICAP1 acts as a novel negative regulator of sprouting angiogenesis, and because a CCM1 loss is correlated with reduction of ICAP1 protein stability, 13 this might contribute to the formation of vascular malformations.
What New Information Does This Article Contribute?
• Our study shows that ICAP1 inhibits the formation of novel blood vessels. • ICAP1 acts in a complex interplay with Rho kinase, NOTCH, and Ras signaling. • Our experiments revealed several new genes regulated by ICAP1, most notably NOTCH ligands and target genes, as well as the endothelial-specific molecule (ESM)1.
The pathogenesis of CCMs, which affect 0.5% of the human population, is poorly understood. ICAP1 is a protein interaction partner of CCM1, one of the causative factors for this disease. Our findings suggest that ICAP1 is needed to keep the quiescent endothelial cell phenotype. Loss of ICAP1 led to increased angiogenesis in primary human endothelial cells in vitro and when transplanted into mice. Downregulation of ICAP1 caused increased Rho kinase activity and decreased DELTA-NOTCH signaling. A reduction of NOTCH activity also caused excessive vessel sprouting. ICAP1 and NOTCH strongly repressed the expression of ESM1, which acted as a proangiogenic molecule. Taken together, these data suggest that ICAP1 acts together with CCM1 for maintaining vascular quiescence. Future studies should reveal whether ICAP1 mutations contribute to the pathogenesis of cavernous malformations.
